-
Major Announcement! Top 10 Research Advances in Chinese Hematology in 2023 Revealed
On January 7th, the Fourth Chinese Hematology Development Conference unveiled the “Top 10 Research Advances in Chinese Hematology in 2023.” The scientific advancements recommended as the “Top 10 Research Advances…
-
2024 CASH | Professor ZhiJian Xiao : Breaking Through Tradition, Marching Towards the Future, The Perfect Integration of Precision Diagnosis and Digital Science
“Oncology Frontier – Hematology Frontier“: As China’s population ages, the incidence of myelodysplastic syndromes (MDS) and myeloproliferative neoplasms (MPN) is rising annually. As an expert deeply involved in MDS, MPN,…
-
2024 CASH | Professor XiaoFan Zhu : Immunotherapy Strategy Brings Greater Benefits to Children with ALL
“Oncology Frontier – Hematology Frontier“: In recent years, immunotherapy has made groundbreaking progress in treating pediatric ALL, especially in children with relapsed or refractory ALL. Professor XiaoFan Zhu: The significant improvements in…
-
2024 CASH丨Professor RongFu : Progress in the Study of Hematological Toxicity Related to CAR-T Therapy
From January 5th to 7th, 2024, the 4th China Hematology Science Development Conference (CASH) opened in Tianjin. Professor Rong Fu of Tianjin Medical University General Hospital delivered an insightful lecture titled…
-
2024 CASH | Professor LuGui Qiu : Continuous Advances in New Drugs, The Road to Cure Multiple Myeloma is Being Realized
“Oncology Frontier – Hematology Frontier“: What are the challenges and obstacles on the path to curing multiple myeloma? Professor LuGui Qiu : Multiple myeloma (MM), as one of the common malignant…
-
2024 CASH | Professor Lei Zhang : Gene Therapy Based on AAV Vector Brings Hope for Cure to Hemophilia Patients
“Oncology Frontier – Hematology Frontier“: In recent years, gene therapy mediated by adeno-associated virus (AAV) has made significant breakthroughs in the treatment of hemophilia. Could you please start by explaining the…
-
2024 CASH丨Professor Jun Shi : Gene Therapy for β-Thalassemia Using Lentiviral Vectors
From January 5th to 7th, 2024, the 4th China Hematology Development Conference (CASH) opened grandly in Tianjin. Professor Jun Shi from the Institute of Hematology of the Chinese Academy of…
-
2024 CASH | Professor Jun Ma : From ASH to CASH, the Mission of Serving Patients and Strengthening Innovation Remains Unchanged
From ASH to CASH, the Commitment to “Everything for the Patient” Remains Unchanged “Oncology Frontier – Hematology Frontier“: Professor Jun Ma, what do you think are the significant implications of domestic…
Connecting Medical Expertise through Media